- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 1/107 - General processes for the preparation of peptides by chemical modification of precursor peptides
Patent holdings for IPC class C07K 1/107
Total number of patents in this class: 1178
10-year publication summary
|
78
|
75
|
73
|
84
|
78
|
99
|
84
|
101
|
119
|
47
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19918 |
29 |
| Forschungsverbund Berlin e.V. | 192 |
17 |
| Ludwig-Maximilians-Universitat Munchen | 344 |
15 |
| Janssen Pharmaceutica N.V. | 3392 |
14 |
| Bristol-myers Squibb Company | 4898 |
13 |
| Massachusetts Institute of Technology | 10057 |
13 |
| Quiapeg Pharmaceuticals AB | 45 |
13 |
| President and Fellows of Harvard College | 5976 |
12 |
| Pfizer Inc. | 3387 |
11 |
| Takeda Pharmaceutical Company Limited | 2713 |
10 |
| Novo Nordisk A/S | 2282 |
10 |
| NBE Therapeutics AG | 39 |
9 |
| New York University | 1748 |
9 |
| Bicyclerd Limited | 144 |
9 |
| F. Hoffmann-La Roche AG | 7925 |
8 |
| Amgen Inc. | 4074 |
8 |
| Roche Sequencing Solutions, Inc. | 648 |
8 |
| Aileron Therapeutics, Inc. | 80 |
7 |
| Hybio Pharmaceutical Co., Ltd. | 121 |
7 |
| Universiteit Gent | 1331 |
7 |
| Other owners | 949 |